KLRK1 and neoplasm: NK cells, as core effector cells of the innate immune system, exert anti-tumor functions through the activation of surface receptors such as NKG2D and the release of cytotoxic molecules, including Granzyme B and Perforin (Christodoulou et al., 2021; Khaleafi et al., 2023).